Seed Round

Kensington Capital's sixth SPAC begins trading its warrants separately, signaling the next phase in its search for a high-growth automotive or AI company.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.

With backing from Mayo Clinic, a startup's AI promises to slash biomarker analysis from weeks to minutes, accelerating cancer care and drug discovery.

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

Geviti Health has launched a first-of-its-kind free AI platform to analyze bloodwork, promising to make preventative health more accessible than ever.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

A first-in-class AI software, neuropacs™, gains FDA clearance, promising to help doctors differentiate complex Parkinsonian syndromes with high accuracy.

AI pioneer Adaptive ML hires a new CMO and CRO, signaling an aggressive push to turn its advanced Reinforcement Learning tech into commercial supremacy.

With backing from AI leaders, Helical’s virtual lab aims to turn powerful models into reproducible drug discovery systems, tackling a key industry bottleneck.

As Ontario hospitals face a financial crisis, a major innovation week aims to connect Canadian startups with global capital to solve healthcare's biggest challenges.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

Evaline Tsai's promotion at Gigascale Capital highlights a new VC playbook where deep scientific expertise is crucial for funding our physical economy's future.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.